Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells

Carcinogenesis

Volumn 33, Issue 12, 2012, Pages 2369-2376

  Ridgway, Rachel A ^a   Serrels, Bryan ^b   Mason, Susan ^a   Kinnaird, Andrew ^b   Muir, Morwenna ^b   Patel, Hitesh ^b   Muller, William J ^c   Sansom, Owen J ^a   Brunton, Valerie G ^b  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; FOCAL ADHESION KINASE; INTEGRIN; MYC PROTEIN; PHORBOL ESTER; PROTEIN TYROSINE KINASE; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS CELL; HAIR FOLLICLE; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PAPILLOMA; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; STEM CELL MOBILIZATION; TRANSCRIPTION INITIATION; WNT SIGNALING PATHWAY;

EID: 84870409562     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs284     Document Type: Article

References (52)

1. Gabarra-Niecko, V. et al. (2003) FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev., 22, 359-374.
2. Siesser, P.M. et al. (2006) The signaling and biological implications of FAK overexpression in cancer. Clin. Cancer Res., 12(11 Pt 1), 3233-3237.
3. Brunton, V.G. et al. (2008) Src and focal adhesion kinase as therapeutic targets in cancer. Curr. Opin. Pharmacol., 8, 427-432.
4. Parsons, J.T. et al. (2008) Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention. Clin. Cancer Res., 14, 627-632.
5. Schlaepfer, D.D. et al. (2004) Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim. Biophys. Acta, 1692, 77-102.
6. Lahlou, H. et al. (2007) Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression. Proc. Natl. Acad. Sci. U.S.A., 104, 20302-20307.
7. McLean, G.W. et al. (2004) Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. Genes Dev., 18, 2998-3003.
8. Blanpain, C. et al. (2006) Epidermal stem cells of the skin. Annu. Rev. Cell Dev. Biol., 22, 339-373.
9. Niemann, C. (2006) Controlling the stem cell niche: right time, right place, right strength. Bioessays, 28, 1-5.
10. Reya, T. et al. (2005) Wnt signalling in stem cells and cancer. Nature, 434, 843-850.
11. Watt, F.M. et al. (2006) Epidermal stem cells: an update. Curr. Opin. Genet. Dev., 16, 518-524.
12. Malanchi, I. et al. (2008) Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature, 452, 650-653.
13. Harada, N. et al. (1999) Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J., 18, 5931-5942.
14. Marcotte, R. et al. (2012) Mammary epithelial-specific disruption of c-Src impairs cell cycle progression and tumorigenesis. Proc. Natl. Acad. Sci. U.S.A., 109, 2808-2813.
15. Serrels, B. et al. (2009) A novel Src kinase inhibitor reduces tumour formation in a skin carcinogenesis model. Carcinogenesis, 30, 249-257.
16. Batlle, E. et al. (2002) Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell, 111, 251-263.
17. Braun, K.M. et al. (2003) Manipulation of stem cell proliferation and lineage commitment: visualisation of label-retaining cells in wholemounts of mouse epidermis. Development, 130, 5241-5255.
18. Cotsarelis, G. et al. (1990) Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell, 61, 1329-1337.
19. Perez-Losada, J. et al. (2003) Stem-cell hierarchy in skin cancer. Nat. Rev. Cancer, 3, 434-443.
20. Blanpain, C. et al. (2004) Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell, 118, 635-648.
21. Braun, K.M. et al. (2004) Epidermal label-retaining cells: background and recent applications. J. Investig. Dermatol. Symp. Proc., 9, 196-201.
22. Kangsamaksin, T. et al. (2007) A perspective on murine keratinocyte stem cells as targets of chemically induced skin cancer. Mol. Carcinog., 46, 579-584.
23. Mitra, S.K. et al. (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr. Opin. Cell Biol., 18, 516-523.
24. Parsons, J.T. (2003) Focal adhesion kinase: the first ten years. J. Cell. Sci., 116(Pt 8), 1409-1416.
25. Finn, R.S. et al. (2007) Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basaltype/" triple-negative" breast cancer cell lines growing in vitro. Breast Cancer Res. Treat., 105, 319-326.
26. Matsumoto, T. et al. (2002) Overexpression of a constitutively active form of c-src in skin epidermis increases sensitivity to tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Mol. Carcinog., 33, 146-155.
27. Yagi, R. et al. (2007) C-terminal Src kinase controls development and maintenance of mouse squamous epithelia. EMBO J., 26, 1234-1244.
28. Stein, P.L. et al. (1992) pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell, 70, 741-750.
29. Stein, P.L. et al. (1994) Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev., 8, 1999-2007.
30. Plé, P.A. et al. (2004) Discovery of a new class of anilinoquinazoline inhibitors with high affinity and specificity for the tyrosine kinase domain of c-Src. J. Med. Chem., 47, 871-887.
31. Copland, M. et al. (2005) Evolving molecular therapy for chronic myeloid leukaemia-are we on target? Hematology, 10, 349-359.
32. Crampton, S.P. et al. (2009) Integration of the beta-catenin-dependent Wnt pathway with integrin signaling through the adaptor molecule Grb2. PLoS ONE, 4, e7841.
33. Fonar, Y. et al. (2011) Focal adhesion kinase protein regulates Wnt3a gene expression to control cell fate specification in the developing neural plate. Mol. Biol. Cell, 22, 2409-2421.
34. Samuel, M.S. et al. (2011) Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell, 19, 776-791.
35. Järvinen, E. et al. (2006) Continuous tooth generation in mouse is induced by activated epithelial Wnt/beta-catenin signaling. Proc. Natl. Acad. Sci. U.S.A., 103, 18627-18632.
36. Lo Celso, C. et al. (2004) Transient activation of beta-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumours. Development, 131, 1787-1799.
37. Van Mater, D. et al. (2003) Transient activation of beta -catenin signaling in cutaneous keratinocytes is sufficient to trigger the active growth phase of the hair cycle in mice. Genes Dev., 17, 1219-1224.
38. Rodriguez-Puebla, M.L. et al. (1998) Synchronized proliferation induced by 12-O-tetradecanoylphorbol-13-acetate treatment of mouse skin: an in vivo model for cell cycle regulation. Cell Growth Differ., 9, 31-39.
39. Arnold, I. et al. (2001) c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr. Biol., 11, 558-568.
40. Waikel, R.L. et al. (2001) Deregulated expression of c-Myc depletes epidermal stem cells. Nat. Genet., 28, 165-168.
41. Essayem, S. et al. (2006) Hair cycle and wound healing in mice with a keratinocyte-restricted deletion of FAK. Oncogene, 25, 1081-1089.
42. Andl, T. et al. (2002) WNT signals are required for the initiation of hair follicle development. Dev. Cell, 2, 643-653.
43. Gat, U. et al. (1998) De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell, 95, 605-614.
44. Huelsken, J. et al. (2001) Beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell, 105, 533-545.
45. Lowry, W.E. et al. (2005) Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells. Genes Dev., 19, 1596-1611.
46. Silva-Vargas, V. et al. (2005) Beta-catenin and Hedgehog signal strength can specify number and location of hair follicles in adult epidermis without recruitment of bulge stem cells. Dev. Cell, 9, 121-131.
47. Coluccia, A.M. et al. (2006) SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling. Cancer Res., 66, 2279-2286.
48. Karni, R. et al. (2005) Active Src elevates the expression of beta-catenin by enhancement of cap-dependent translation. Mol. Cell. Biol., 25, 5031-5039.
49. Yokoyama, N. et al. (2009) Dishevelled-2 docks and activates Src in a Wntdependent manner. J. Cell. Sci., 122(Pt 24), 4439-4451.
50. Oskarsson, T. et al. (2006) Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene. Genes Dev., 20, 2024-2029.
51. Ashton, G.H. et al. (2010) Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling. Dev. Cell, 19, 259-269.
52. Schober, M. et al. (2011) Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling. Proc. Natl. Acad. Sci. U.S.A., 108, 10544-10549.